We are live on ! Find out more
KURA icon

Kura Oncology
KURA

116 hedge funds and large institutions have $529M invested in Kura Oncology in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 27 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 27

90% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 10

8% more funds holding

Funds holding: 107 → 116 (+9)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

2% less capital invested

Capital invested by funds: $541M → $529M (-$11.5M)

8.96% less ownership

Funds ownership: 88.57% → 79.61% (-9%)

30% less call options, than puts

Call options by funds: $263K | Put options by funds: $375K

Holders
116
Holders Change
+9
Holders Change %
+8.41%
% of All Funds
2.65%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
19
Increased
54
Reduced
27
Closed
10
Calls
$263K
Puts
$375K
Net Calls
-$112K
Net Calls Change
+$2.04M

Top Buyers

1
EAM
Eagle Asset Management
Florida
+$13.5M
2
CTA
Carillon Tower Advisers
Florida
+$11M
3
BlackRock
BlackRock
New York
+$7.55M
4
KCM
Kennedy Capital Management
Missouri
+$5.53M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.7M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.7M
2
GPP
Great Point Partners
Connecticut
-$9.74M
3
SFM
Sphera Funds Management
Israel
-$6.41M
4
Invesco
Invesco
Georgia
-$3.17M
5
SCM
Sio Capital Management
New York
-$2.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$68.3M -$32.6K -1,700 -0%
BlackRock
2
BlackRock
New York
$41.9M +$7.55M +393,872 +20%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$40M -$20.7M -1,080,909 -32%
GPP
4
Great Point Partners
Connecticut
$37.1M -$9.74M -508,004 -19%
EAM
5
Eagle Asset Management
Florida
$36.2M +$13.5M +703,282 +51%
BI
6
BVF Inc
California
$35.3M -$795K -41,490 -2%
Victory Capital Management
7
Victory Capital Management
Texas
$26.9M +$902K +47,070 +3%
CTA
8
Carillon Tower Advisers
Florida
$26.3M +$11M +576,221 +62%
Vanguard Group
9
Vanguard Group
Pennsylvania
$25.5M +$571K +29,785 +2%
State Street
10
State Street
Massachusetts
$20.5M +$2.59M +135,165 +13%
PHS
11
PFM Health Sciences
California
$19.3M +$317K +16,533 +2%
BC
12
Boxer Capital
California
$14.8M – – –
SCM
13
Sio Capital Management
New York
$12.7M -$2.12M -110,346 -13%
Millennium Management
14
Millennium Management
New York
$7.73M -$1.59M -82,925 -16%
RSCM
15
Rock Springs Capital Management
Maryland
$7.09M +$95.9K +5,000 +1%
KCM
16
Kennedy Capital Management
Missouri
$6.75M +$5.53M +288,579 +297%
Point72 Asset Management
17
Point72 Asset Management
Connecticut
$6.61M +$4.7M +245,406 +185%
Northern Trust
18
Northern Trust
Illinois
$6.6M +$1.11M +57,897 +18%
CS
19
Candriam SCA
Luxembourg
$6.41M -$307K -16,000 -4%
NC
20
Nexthera Capital
New York
$5.45M -$1.34M -69,923 -18%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$5.44M +$686K +35,794 +13%
SSA
22
Schonfeld Strategic Advisors
New York
$4.66M +$3.5M +182,400 +217%
PM
23
Prosight Management
Texas
$4.44M -$657K -34,256 -12%
SI
24
Sofinnova Investments
California
$4.33M +$1.52M +79,485 +47%
DCM
25
DAFNA Capital Management
California
$4.21M +$19.2K +1,000 +0.4%
1
2 3 4 5

KURA Hedge Fund Activity: Q3 2018 in Review

116 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2018, worth a combined $529M — down 2.1% from $541M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new KURA positions and 10 closed out — a net gain of 9 holders — while 54 added to existing stakes and 27 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $13.5M. The largest seller was Fidelity Investments, cutting an estimated $20.7M.

  • 116 institutional investors held Kura Oncology (KURA) as of Q3 2018, up from 107 in Q2 2018.
  • Funds reported $529M of Kura Oncology stock for Q3 2018, down 2.1% quarter-over-quarter.
  • 19 funds opened new Kura Oncology positions in Q3 2018 and 10 closed out, a net change of +9 holders.
  • The largest Kura Oncology buyer in Q3 2018 was Eagle Asset Management, an estimated $13.5M added.
  • The largest Kura Oncology seller in Q3 2018 was Fidelity Investments, an estimated $20.7M sold.

Based on aggregated 13F filings for Q3 2018.